The Urinalysis Market, estimated at USD 1,941.8 Mn in 2025, is expected to exhibit a CAGR of 6.5% and reach USD 3,017.5 Mn by 2032.
The market growth is driven by rising demand for accurate and early disease detection, supported by advances in molecular diagnostics, imaging, and point-of-care testing. Growing focus on personalized medicine, supportive healthcare policies, and ongoing R&D investments are creating new opportunities for industry players.
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/urinalysis-market-382
Consumables segment held dominant position in the global urinalysis market in 2022, accounting for 68.1% share in terms of value, increasing approval and launch of new products is expected to propel growth of the segment during the forecast period.
Market Trends:
Technological advancements is one of the key trends expected to augment the growth of the global urinalysis market. Continuous technological advancements in urinalysis equipment and point-of-care (POC) testing devices have improved accuracy, speed, and ease of use, promoting the use or adoption of urinalysis tests across various healthcare settings. Technological advancements have also paved the way for significant progress in automated urinalysis. Each system uses a different technology to classify/quantify urine sediments and offers an improvement in standardization over manual microscopy by eliminating potential inter-technician variability during slide interpretation. This in turn is also expected to augment the growth of the market.
Competitive Landscape:
Major players operating in the global urinalysis market include Arkray Inc., Abbott Laboratories, Eiken Chemical Co. Ltd., Sysmex Corporation, Siemens Healthineers AG, Cardinal Health Inc., Acon Laboratories Inc., Bio-Rad Laboratories Inc., Becton, Dickinson & Company, F. Hoffmann-La Roche Ltd., and Danaher Corporation (Beckman Coulter Inc.), among others.
Recent Developments:
In September 2022, Sysmex Corp. announced the launch of the new UF-1500 fully automatic urine particle analysing tool for urine sediment testing, strengthening and expanding its product portfolio while maintaining its market position.
In July 2022, Arkray announced the launch of AUTION AI-4510, an innovative automated urine sediment analyzer with built-in capabilities to speed up operations and with on-board auto dilution that eliminates waste and ensures greater accuracy.
Contact Us